JPRN-UMIN000029115已完成未知
A prospective feasibility study of allogeneic hematopoietic stem cell transplantation using once daily intravenous busulfan and fludarabine as conditioning regimen - Flu plus Bu Once Daily
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
Because the new treatment schedule was approved by the government, we stopped the study which assessed the feasibility of the same schedule of administration.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
不适用
A prospective feasibility study of cord blood transplant using once daily intravenous busulfan and fludarabine plus melphalan as conditioning regimeHematological malignancyJPRN-UMIN000030308Osaka International Cancer Institute
已完成
2 期
MEG dementia studycognitively unimpaired, mild cognitive impairment/dementia due to Alzheime's diseaseD000544JPRN-jRCTs042220078Ono Kenjiro
撤回
2 期
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic ConjunctivitisAllergic ConjunctivitisNCT00375596Bausch & Lomb Incorporated
已完成
1 期
Combination therapy with immune-cell therapy and immune check point inhibitor.malignant tumorJPRN-jRCTc031210185Takimoto Rishu3
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40